Bristol Myers Squibb Acquires Cardiovascular Specialist MyoKardia for US$13.1 B

By Neha Madhwani & Michelle Liu

Pharma Deals Review: Vol 2020 Issue 10 (Table of Contents)

Published: 23 Oct-2020

DOI: 10.3833/pdr.v2020.i10.2565     ISSN: 1756-7874

Section: Mergers & Acquisitions



In the third largest M&A deal of 2020 so far, Bristol Myers Squibb (BMS) has agreed to acquire MyoKardia for US$13...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details